Treatment of tumour tissue with radio‐frequency hyperthermia (using antibody‐carrying nanoparticles)

Abstract Intelligent inorganic nanoparticles were designed and produced for use in imaging and annihilating tumour cells by radio‐frequency (RF) hyperthermia. Nanoparticles synthesised to provide RF hyperthermia must have magnetite properties. For this purpose, magnetite nanoparticles were first syn...

Full description

Saved in:
Bibliographic Details
Main Authors: Reza Didarian, Ibrahim Vargel
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:IET Nanobiotechnology
Online Access:https://doi.org/10.1049/nbt2.12061
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559602188681216
author Reza Didarian
Ibrahim Vargel
author_facet Reza Didarian
Ibrahim Vargel
author_sort Reza Didarian
collection DOAJ
description Abstract Intelligent inorganic nanoparticles were designed and produced for use in imaging and annihilating tumour cells by radio‐frequency (RF) hyperthermia. Nanoparticles synthesised to provide RF hyperthermia must have magnetite properties. For this purpose, magnetite nanoparticles were first synthesised by the coprecipitation method (10–15 NM). These superparamagnetic nanoparticles were then covered with gold ions without losing their magnetic properties. In this step, gold ions are reduced around the magnetite nanoparticles. Surface modification of the gold‐coated magnetic nanoparticles was performed in the next step. A self‐assembled monolayer was created using cysteamine (2‐aminoethanethiol) molecules, which have two different end groups (SH and NH2). These molecules react with the gold surface by SH groups. The NH2 groups give a positive charge to the nanoparticles. After that, a monoclonal antibody (Monoclonal Anti‐N‐CAM Clone NCAM‐OB11) was immobilised by the 1‐ethyl‐3‐(3‐dimethylaminopropyl)carbodiimide/N‐hydroxysuccinimide method. Then, the antenna RF system (144.00015 MHz) was created for RF hyperthermia. The antibody‐nanoparticle binding rate and cytotoxicity tests were followed by in vitro and in vivo experiments. As the main result, antibody‐bound gold‐coated magnetic nanoparticles were successfully connected to tumour cells. After RF hyperthermia, the tumour size decreased owing to apoptosis and necrosis of tumour cells.
format Article
id doaj-art-0a7aa150f18e437899818716b23e4c4a
institution Kabale University
issn 1751-8741
1751-875X
language English
publishDate 2021-10-01
publisher Wiley
record_format Article
series IET Nanobiotechnology
spelling doaj-art-0a7aa150f18e437899818716b23e4c4a2025-02-03T01:29:38ZengWileyIET Nanobiotechnology1751-87411751-875X2021-10-0115863965310.1049/nbt2.12061Treatment of tumour tissue with radio‐frequency hyperthermia (using antibody‐carrying nanoparticles)Reza Didarian0Ibrahim Vargel1Department of Nanotechnology and Nanomedicine Hacettepe University Beytepe Campus Ankara TurkeyDepartment of Plastic Reconstructive and Aesthetic Surgery Hacettepe University, Sıhhiye Ankara TurkeyAbstract Intelligent inorganic nanoparticles were designed and produced for use in imaging and annihilating tumour cells by radio‐frequency (RF) hyperthermia. Nanoparticles synthesised to provide RF hyperthermia must have magnetite properties. For this purpose, magnetite nanoparticles were first synthesised by the coprecipitation method (10–15 NM). These superparamagnetic nanoparticles were then covered with gold ions without losing their magnetic properties. In this step, gold ions are reduced around the magnetite nanoparticles. Surface modification of the gold‐coated magnetic nanoparticles was performed in the next step. A self‐assembled monolayer was created using cysteamine (2‐aminoethanethiol) molecules, which have two different end groups (SH and NH2). These molecules react with the gold surface by SH groups. The NH2 groups give a positive charge to the nanoparticles. After that, a monoclonal antibody (Monoclonal Anti‐N‐CAM Clone NCAM‐OB11) was immobilised by the 1‐ethyl‐3‐(3‐dimethylaminopropyl)carbodiimide/N‐hydroxysuccinimide method. Then, the antenna RF system (144.00015 MHz) was created for RF hyperthermia. The antibody‐nanoparticle binding rate and cytotoxicity tests were followed by in vitro and in vivo experiments. As the main result, antibody‐bound gold‐coated magnetic nanoparticles were successfully connected to tumour cells. After RF hyperthermia, the tumour size decreased owing to apoptosis and necrosis of tumour cells.https://doi.org/10.1049/nbt2.12061
spellingShingle Reza Didarian
Ibrahim Vargel
Treatment of tumour tissue with radio‐frequency hyperthermia (using antibody‐carrying nanoparticles)
IET Nanobiotechnology
title Treatment of tumour tissue with radio‐frequency hyperthermia (using antibody‐carrying nanoparticles)
title_full Treatment of tumour tissue with radio‐frequency hyperthermia (using antibody‐carrying nanoparticles)
title_fullStr Treatment of tumour tissue with radio‐frequency hyperthermia (using antibody‐carrying nanoparticles)
title_full_unstemmed Treatment of tumour tissue with radio‐frequency hyperthermia (using antibody‐carrying nanoparticles)
title_short Treatment of tumour tissue with radio‐frequency hyperthermia (using antibody‐carrying nanoparticles)
title_sort treatment of tumour tissue with radio frequency hyperthermia using antibody carrying nanoparticles
url https://doi.org/10.1049/nbt2.12061
work_keys_str_mv AT rezadidarian treatmentoftumourtissuewithradiofrequencyhyperthermiausingantibodycarryingnanoparticles
AT ibrahimvargel treatmentoftumourtissuewithradiofrequencyhyperthermiausingantibodycarryingnanoparticles